CanSino’s Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?
The company’s Convidecia has received emergency-use authorization from the World Health Organization, becoming the third Chinese vaccine to get that nod Key Takeaways: CanSino’s Covid-19 vaccine Convidecia will be admitted…
RELATED ARTICLES
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
- China’s mRNA pioneer Stemirna faces post-Covid reinvention test
-
With healthier finances, Clover Bio shifts to flu and RSV vaccines
2197.HK
- Health Guard plans dual listing to fund HPV vaccine fight
-
FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
6185.HK 688185.SHG
-
FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine
6185.HK 688185.SHG
- CHINA BULLETIN: Weak Economic Signals All Around
Discover hidden China stock gems in our weekly newsletter